Vitamin D and Microbiota in Cystic Fibrosis
Completed · Not applicable · Has a placebo group
Conditions studied: Vitamin D Deficiency, Cystic Fibrosis
In brief
The objective of this study is to assess the effects of a high-dose vitamin D3 on the composition of gut and lung microbiota in adolescents and adults with cystic fibrosis who are vitamin D deficient.
Key facts
- Study ID
- NCT02589444
- Run by
- Emory University
- People needed
- 41
- Starts
- 2015-12-01
- Expected to finish
- 2017-04-01
- Last updated by the study team
- 2017-06-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Presenting to the Cystic fibrosis clinic for routine follow up of cystic fibrosis
- Serum 25(OH)D concentrations obtained within 2 months of enrollment
- Able to tolerate oral medications
You may not qualify if…
- Inability to obtain or declined informed consent from the subject and/or legally authorized representative
- Pregnancy or plans to become pregnant in the next 3 months
- History of disorders associated with hypercalcemia including parathyroid disease
- Current hypercalcemia (albumin-corrected serum calcium >10.8 mg/dL or ionized calcium >5.2 mg/dL)
- History of nephrolithiasis with active symptoms within the past two years
- Chronic kidney disease worse than stage III (<60 ml/min)
- Current significant hepatic dysfunction total bilirubin > 2.5 mg/dL with direct bilirubin > 1.0 mg/dL
- Current use of cytotoxic or immunosuppressive drugs
- History of AIDS
- History of illicit drug abuse (defined as history of enrollment into a drug rehabilitation program or hospital visits due to drug use within the past 3 years or any use of the following drugs in the past 6 months (cocaine, opiates, amphetamines, marijuana) or any positive toxicology screen for (cocaine, opiates, amphetamines, marijuana)
- Too ill to participate in study based on investigator's or study team's opinion
- Current enrollment in another intervention trial
- In addition we amended our study with three additional criteria 11) systemic antibiotic use in the last 4 weeks, 12) use of probiotics and, 13) inflammatory bowel disease, four months after the start of the study and after 12 subjects were randomized, as we considered that these factors may also influence our study endpoints. Of the 12 subjects who were randomized, only 4 would have been excluded.
Where it is running
- Emory Clinic — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.